• Stereotyped subset 8, an aggressive entity associated with Richter transformation, is characterized by a unique chromatin activation profile.

  • A set of 209 de novo active regions in subset 8 are associated with 113 overexpressed genes, potentially related to Richter transformation.

The chromatin activation landscape of chronic lymphocytic leukemia (CLL) with stereotyped B-cell receptor immunoglobulin is currently unknown. In this study, we report the results of a whole-genome chromatin profiling of histone 3 lysine 27 acetylation of 22 CLLs from major subsets, which were compared against nonstereotyped CLLs and normal B-cell subpopulations. Although subsets 1, 2, and 4 did not differ much from their nonstereotyped CLL counterparts, subset 8 displayed a remarkably distinct chromatin activation profile. In particular, we identified 209 de novo active regulatory elements in this subset, which showed similar patterns with U-CLLs undergoing Richter transformation. These regions were enriched for binding sites of 9 overexpressed transcription factors. In 78 of 209 regions, we identified 113 candidate overexpressed target genes, 11 regions being associated with more than 2 adjacent genes. These included blocks of up to 7 genes, suggesting local coupregulation within the same genome compartment. Our findings further underscore the uniqueness of subset 8 CLL, notable for the highest risk of Richter’s transformation among all CLLs and provide additional clues to decipher the molecular basis of its clinical behavior.

1.
Kipps
TJ
,
Stevenson
FK
,
Wu
CJ
, et al
.
Chronic lymphocytic leukaemia
.
Nat Rev Dis Primers
.
2017
;
3
:
17008
.
2.
Fais
F
,
Ghiotto
F
,
Hashimoto
S
, et al
.
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors
.
J Clin Invest
.
1998
;
102
(
8
):
1515
-
1525
.
3.
Agathangelidis
A
,
Chatzidimitriou
A
,
Gemenetzi
K
, et al
.
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
.
Blood
.
2021
;
137
(
10
):
1365
-
1376
.
4.
Strefford
JC
,
Sutton
LA
,
Baliakas
P
, et al
.
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2
.
Leukemia
.
2013
;
27
(
11
):
2196
-
2199
.
5.
Baliakas
P
,
Hadzidimitriou
A
,
Sutton
LA
, et al
.
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study
.
Lancet Haematol
.
2014
;
1
(
2
):
e74
-
e84
.
6.
Jaramillo
S
,
Agathangelidis
A
,
Schneider
C
, et al
.
Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG)
.
Haematologica
.
2020
;
105
(
11
):
2598
-
2607
.
7.
Bhoi
S
,
Ljungstrom
V
,
Baliakas
P
, et al
.
Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: the case of subset #2
.
Epigenetics
.
2016
;
11
(
6
):
449
-
455
.
8.
Papakonstantinou
N
,
Ntoufa
S
,
Tsagiopoulou
M
, et al
.
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia
.
Int J Cancer
.
2019
;
144
(
11
):
2695
-
2706
.
9.
Beekman
R
,
Chapaprieta
V
,
Russinol
N
, et al
.
The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia
.
Nat Med
.
2018
;
24
(
6
):
868
-
880
.
10.
Ott
CJ
,
Federation
AJ
,
Schwartz
LS
, et al
.
Enhancer architecture and essential core regulatory circuitry of chronic lymphocytic leukemia
.
Cancer Cell
.
2018
;
34
(
6
):
982
-
995.e7
.
11.
Nadeu
F
,
Royo
R
,
Massoni-Badosa
R
, et al
.
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
.
Nat Med
.
2022
;
28
(
8
):
1662
-
1671
.
12.
Rossi
D
,
Spina
V
,
Cerri
M
, et al
.
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome
.
Clin Cancer Res
.
2009
;
15
(
13
):
4415
-
4422
.
13.
Vilarrasa-Blasi
R
,
Soler-Vila
P
,
Verdaguer-Dot
N
, et al
.
Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation
.
Nat Commun
.
2021
;
12
(
1
):
651
.
14.
Tsagiopoulou
M
,
Pechlivanis
N
,
Maniou
MC
,
Psomopoulos
F
.
InterTADs: integration of multi-omics data on topologically associated domains, application to chronic lymphocytic leukemia
.
NAR Genom Bioinform
.
2022
;
4
(
1
):
lqab121
.
15.
Tsagiopoulou
M
,
Chapaprieta
V
,
Duran-Ferrer
M
, et al
.
Chronic lymphocytic leukemias with trisomy 12 show a distinct DNA methylation profile linked to altered chromatin activation
.
Haematologica
.
2020
;
105
(
12
):
2864
-
2867
.
16.
Porpaczy
E
,
Bilban
M
,
Heinze
G
, et al
.
Gene expression signature of chronic lymphocytic leukaemia with trisomy 12
.
Eur J Clin Invest
.
2009
;
39
(
7
):
568
-
575
.
17.
Hartmann
L
,
Dutta
S
,
Opatz
S
, et al
.
ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation
.
Nat Commun
.
2016
;
7
:
11733
.
18.
Chen
Z
,
Wei
X
,
Wang
X
, et al
.
NDUFA4L2 promotes glioblastoma progression, is associated with poor survival, and can be effectively targeted by apatinib
.
Cell Death Dis
.
2021
;
12
(
4
):
377
.
19.
Niu
J
,
Sun
Y
,
Chen
B
, et al
.
Fatty acids and cancer-amplified ZDHHC19 promote STAT3 activation through S-palmitoylation
.
Nature
.
2019
;
573
(
7772
):
139
-
143
.
20.
Severin
F
,
Frezzato
F
,
Visentin
A
, et al
.
In chronic lymphocytic leukemia the JAK2/STAT3 pathway is constitutively activated and its inhibition leads to CLL cell death unaffected by the protective bone marrow microenvironment
.
Cancers (Basel)
.
2019
;
11
(
12
):
1939
.
21.
Zapata
JM
,
Krajewska
M
,
Morse
HC
,
Choi
Y
,
Reed
JC
.
TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice
.
Proc Natl Acad Sci U S A
.
2004
;
101
(
47
):
16600
-
16605
.
22.
Munzert
G
,
Kirchner
D
,
Stobbe
H
, et al
.
Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis
.
Blood
.
2002
;
100
(
10
):
3749
-
3756
.
23.
Hernandez-Fernaud
JR
,
Ruengeler
E
,
Casazza
A
, et al
.
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity
.
Nat Commun
.
2017
;
8
:
14206
.
24.
Han
Q
,
Zhang
Q
,
Song
H
,
Bamme
Y
,
Song
C
,
Ge
Z
.
FBXW4 is highly expressed and associated with poor survival in acute myeloid leukemia
.
Front Oncol
.
2020
;
10
:
149
.
25.
Zhu
H
,
Zhang
H
,
Pei
Y
, et al
.
Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression
.
J Exp Clin Cancer Res
.
2021
;
40
(
1
):
57
.
You do not currently have access to this content.
Sign in via your Institution